Addition of Exenatide to Basal Insulin for Type 2 DiabetesAddition of Exenatide to Basal Insulin for Type 2 Diabetes

This study assessed the benefits and risks of adding exenatide, a GLP-1 receptor agonist, in patients with type 2 diabetes who have not gained glycemic control on basal insulin alone. International Journal of Clinical Practice

Source: Medscape Today Headlines - January 30, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news